1-4 of 4
Luis Borges
Close
Sort by
Journal Articles

Development of Multi-Engineered iPSC-Derived CAR-NK Cells for the Treatment of B-Cell Malignancies

Luis Borges, Mark A Wallet, Chiamin-Liao Bullaughey, Michael F Naso, Buddha Gurung, Shelby Keating, Jill M Carton, John C Wheeler, Liam Campion, Mark Mendonca, Heidi K Jessup, Marilda Beqiri, Diana Chin, Hillary Millar Quinn, Barry A Morse
Journal: Blood
Blood (2021) 138 (Supplement 1): 1729.
https://doi.org/10.1182/blood-2021-148438
Published: 2021
Journal Articles

Induced Pluripotent Stem Cell-Derived Gamma Delta CAR-T Cells for Cancer Immunotherapy

Mark A Wallet, Toshinobu Nishimura, Christina Del Casale, Andriana Lebid, Brenda Salantes, Katherine Santostefano, Sydney Bucher, Mark Mendonca, Marilda Beqiri, Lucas J Thompson, Barry A Morse, Hillary Millar Quinn, Luis Borges
Journal: Blood
Blood (2021) 138 (Supplement 1): 2771.
https://doi.org/10.1182/blood-2021-149095
Published: 2021
Journal Articles

Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition

David E. Sloane, Nicodemus Tedla, Muyiwa Awoniyi, Donald W. MacGlashan, Jr, Luis Borges, K. Frank Austen, Jonathan P. Arm
Journal: Blood
Blood (2004) 104 (9): 2832–2839.
https://doi.org/10.1182/blood-2004-01-0268
Published: 2004
Journal Articles

LIR9, an immunoglobulin-superfamily–activating receptor, is expressed as a transmembrane and as a secreted molecule

Brief Report
Luis Borges, Marek Kubin, Tracy Kuhlman
Journal: Blood
Blood (2003) 101 (4): 1484–1486.
https://doi.org/10.1182/blood-2002-05-1432
Published: 2003